ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/20 | 2,132 | 2,147 | 2,044 | 2,058 | -63 | -3% | 967,800 |
2020/02/19 | 2,138 | 2,167 | 2,100 | 2,121 | +9 | +0.4% | 838,500 |
2020/02/18 | 2,165 | 2,179 | 2,088 | 2,112 | -47 | -2.2% | 996,200 |
2020/02/17 | 2,012 | 2,217 | 2,010 | 2,159 | +147 | +7.3% | 2,436,100 |
2020/02/14 | 1,983 | 2,085 | 1,972 | 2,012 | -11 | -0.5% | 1,584,700 |
2020/02/13 | 2,053 | 2,065 | 2,020 | 2,023 | -32 | -1.6% | 807,400 |
2020/02/12 | 2,070 | 2,077 | 2,039 | 2,055 | ±0 | ±0% | 606,500 |
2020/02/10 | 2,050 | 2,059 | 2,022 | 2,055 | +9 | +0.4% | 506,400 |
2020/02/07 | 2,066 | 2,090 | 2,040 | 2,046 | -19 | -0.9% | 781,000 |
2020/02/06 | 2,080 | 2,090 | 2,049 | 2,065 | +16 | +0.8% | 681,500 |
2020/02/05 | 2,022 | 2,056 | 2,015 | 2,049 | +41 | +2% | 929,600 |
2020/02/04 | 1,950 | 2,014 | 1,942 | 2,008 | +71 | +3.7% | 865,300 |
2020/02/03 | 1,857 | 1,970 | 1,853 | 1,937 | +5 | +0.3% | 1,255,400 |
2020/01/31 | 1,880 | 1,965 | 1,867 | 1,932 | +55 | +2.9% | 1,364,300 |
2020/01/30 | 2,004 | 2,011 | 1,825 | 1,877 | -136 | -6.8% | 2,790,400 |
2020/01/29 | 2,060 | 2,069 | 1,998 | 2,013 | -55 | -2.7% | 911,600 |
2020/01/28 | 2,087 | 2,104 | 2,059 | 2,068 | -28 | -1.3% | 666,700 |
2020/01/27 | 2,041 | 2,109 | 2,035 | 2,096 | -10 | -0.5% | 637,000 |
2020/01/24 | 2,125 | 2,135 | 2,061 | 2,106 | -23 | -1.1% | 781,600 |
2020/01/23 | 2,134 | 2,167 | 2,125 | 2,129 | -11 | -0.5% | 601,600 |
2020/01/22 | 2,135 | 2,193 | 2,131 | 2,140 | +6 | +0.3% | 917,900 |
2020/01/21 | 2,133 | 2,153 | 2,121 | 2,134 | -5 | -0.2% | 373,900 |
2020/01/20 | 2,142 | 2,152 | 2,123 | 2,139 | -9 | -0.4% | 365,500 |
2020/01/17 | 2,142 | 2,159 | 2,135 | 2,148 | -2 | -0.1% | 636,300 |
2020/01/16 | 2,118 | 2,167 | 2,115 | 2,150 | +11 | +0.5% | 774,200 |
2020/01/15 | 2,110 | 2,152 | 2,108 | 2,139 | +35 | +1.7% | 838,600 |
2020/01/14 | 2,129 | 2,129 | 2,092 | 2,104 | -11 | -0.5% | 740,500 |
2020/01/10 | 2,038 | 2,116 | 2,038 | 2,115 | +68 | +3.3% | 987,500 |
2020/01/09 | 2,052 | 2,079 | 2,030 | 2,047 | +35 | +1.7% | 1,038,000 |
2020/01/08 | 2,101 | 2,110 | 1,977 | 2,012 | -105 | -5% | 2,841,100 |
2020/01/07 | 2,127 | 2,156 | 2,115 | 2,117 | ±0 | ±0% | 1,107,200 |
2020/01/06 | 2,150 | 2,176 | 2,110 | 2,117 | -54 | -2.5% | 1,633,800 |
2019/12/30 | 2,260 | 2,261 | 2,162 | 2,171 | -98 | -4.3% | 1,765,500 |
2019/12/27 | 2,272 | 2,295 | 2,242 | 2,269 | -3 | -0.1% | 965,900 |
2019/12/26 | 2,206 | 2,299 | 2,206 | 2,272 | +44 | +2% | 2,002,800 |
2019/12/25 | 2,227 | 2,248 | 2,196 | 2,228 | +6 | +0.3% | 1,393,800 |
2019/12/24 | 2,193 | 2,225 | 2,146 | 2,222 | +41 | +1.9% | 2,159,000 |
2019/12/23 | 2,200 | 2,206 | 2,147 | 2,181 | +16 | +0.7% | 1,369,700 |
2019/12/20 | 2,212 | 2,215 | 2,158 | 2,165 | -37 | -1.7% | 925,200 |
2019/12/19 | 2,190 | 2,214 | 2,177 | 2,202 | +12 | +0.5% | 612,400 |
2019/12/18 | 2,210 | 2,226 | 2,173 | 2,190 | -19 | -0.9% | 805,400 |
2019/12/17 | 2,150 | 2,209 | 2,144 | 2,209 | +59 | +2.7% | 1,083,700 |
2019/12/16 | 2,168 | 2,197 | 2,137 | 2,150 | -55 | -2.5% | 1,568,300 |
2019/12/13 | 2,268 | 2,268 | 2,204 | 2,205 | -49 | -2.2% | 1,543,600 |
2019/12/12 | 2,260 | 2,267 | 2,228 | 2,254 | -13 | -0.6% | 818,600 |
2019/12/11 | 2,261 | 2,295 | 2,247 | 2,267 | +18 | +0.8% | 931,700 |
2019/12/10 | 2,284 | 2,296 | 2,248 | 2,249 | -24 | -1.1% | 854,200 |
2019/12/09 | 2,315 | 2,342 | 2,260 | 2,273 | -44 | -1.9% | 1,269,800 |
2019/12/06 | 2,230 | 2,320 | 2,218 | 2,317 | +83 | +3.7% | 1,467,100 |
2019/12/05 | 2,321 | 2,334 | 2,230 | 2,234 | -83 | -3.6% | 1,856,000 |
1301~
1350
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 90,100円 | +20.3% | - | 0.00% | 159.75倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 342,500円 | +174.2% | - | 0.00% | - | 10.28倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 212,200円 | +4.1% | -3.1% | 2.73% | 18.48倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 54,600円 | +14.3% | - | 3.66% | 22.18倍 | 1.41倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 236,600円 | +16.9% | +33.2% | 2.32% | 12.90倍 | 1.03倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム